For the quarter ending 2025-09-30.
| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| General and administrative | 1,814 | 1,279 | ||
| Research and development | 1,275 | 1,871 | ||
| Total operating expenses | 3,089 | 3,150 | ||
| Loss from operations | -3,089 | -3,150 | ||
| Interest income | 5 | 1 | ||
| Interest expense | 111 | 72 | ||
| Net change in fair value of digital assets | 75 | - | ||
| Net change in fair value of trading marketable securities | 0 | 0 | ||
| Total other income (expense) | -31 | -71 | ||
| Provision for income taxes | 0 | 0 | ||
| Net loss | -3,120 | -3,221 | ||
| Foreign currency translation adjustments | 18 | -68 | ||
| Total other comprehensive income (loss) | 18 | - | ||
| Total comprehensive loss | -3,102 | -3,289 | ||
| Diluted EPS | -3.97 | -5.61 | ||
| Diluted Average Shares | 787,000 | 574,000 | ||
ARTELO BIOSCIENCES, INC. (ATLEW)
ARTELO BIOSCIENCES, INC. (ATLEW)